AABB launched a new website to inform the public, blood collectors and clinicians about COVID-19 convalescent plasma. The website provides information to connect people who have recovered from COVID-19 to AABB-accredited blood centers so that they can potentially donate convalescent plasma to help improve the status of critically ill patients with COVID-19. AABB yesterday also sent a letter to its member hospitals encouraging them to collaborate with their blood supplier by identifying and referring individuals who have recovered from COVID-19 for donation of COVID-19 convalescent plasma. The Food and Drug Administration, which considers COVID-19 convalescent plasma an investigational treatment, recently announced new guidelines permitting its use for patients with moderate or severe COVID-19 infections.

Headline
The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive…
Headline
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year,…
Headline
A study published Aug. 5 by Nature found that COVID-19 infection can reactivate dormant, chronic viruses such as Epstein-Barr and cytomegalovirus. The study…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…